{
  "paper_metadata": {
    "pmid": "32477792",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on the KCNH2 gene variants, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "KCNH2",
      "cdna_notation": "c.unknown",
      "protein_notation": "p.Gly627Ser",
      "genomic_position": "unknown",
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 2,
        "demographics": "pigs used in experimental models",
        "phenotype": "prolonged action potential duration, resistance to atrial fibrillation"
      },
      "penetrance_data": {
        "total_carriers_observed": 2,
        "affected_count": 2,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "demonstrated prolonged action potential duration and resistance to AF",
          "evidence_sentence": "By interrupting the alpha subunit of the IKr channel in the gene-treated pigs, the investigators found an increase in the APD, resistance to burst pacing-induced AF, and increased conversion from AF to sinus rhythm."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "delayed or prevented development of persistent AF",
          "evidence_sentence": "They found that pigs who received gene therapy had markedly longer APD and that the development of persistent AF was delayed or prevented in a rapid atrial pacing model."
        }
      ],
      "functional_data": {
        "summary": "Gene therapy targeting KCNH2 resulted in prolonged action potential duration and resistance to atrial fibrillation.",
        "assays": [
          "epicardial gene painting",
          "electroporation"
        ]
      },
      "segregation_data": "segregates with disease in experimental models",
      "population_frequency": "not applicable in human databases",
      "evidence_level": "strong evidence from animal studies",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The studies were conducted in pigs, and the effects were reversible at two weeks.",
      "key_quotes": [
        "These effects were reversed at two weeks, which correlated with a loss of gene expression.",
        "Notably, however, both studies were of too short a duration to determine the long-term side effects of atrial IKr suppression."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data regarding KCNH2 variants were extracted from the main text."
  }
}